Gynecological health: A missing link in comprehensive treatment monitoring for multiple sclerosis

Melika Arab Bafrani1, Viviana Rios1, Min Ji Kim1

  • 1UCSF Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA.

Multiple Sclerosis (Houndmills, Basingstoke, England)
|June 18, 2025
PubMed

Insights

Disease-modifying therapies for multiple sclerosis (MS) require attention to gynecological health. This review highlights risks like HPV, vaginitis, and herpesvirus infections, offering mitigation strategies for improved quality of life.

Area of Science:

  • Gynecologic Oncology
  • Infectious Diseases
  • Neuroimmunology

Background:

  • Safety monitoring of multiple sclerosis (MS) disease-modifying therapies (DMTs) has historically neglected gynecological health.
  • Neurological consultations often lack a dedicated focus on gynecological well-being in patients with MS.

Purpose of the Study:

  • To review gynecological complications associated with MS DMTs.
  • To outline risk mitigation strategies for clinicians treating women with MS.

Main Methods:

  • Topical review of existing literature on gynecological health in MS patients undergoing DMTs.
  • Categorization of identified complications and associated risk factors.

Main Results:

  • Increased risk of human papilloma virus (HPV) positivity, cervical dysplasia, and cancer.
  • Higher susceptibility to inflammatory vaginitis, infectious vaginitis, and bacterial vaginosis (BV).
  • Increased incidence of herpesvirus infections, including genital Herpes Simplex Virus (HSV).

Conclusions:

  • Proactive gynecological health management is crucial for women with MS on DMTs.
  • Strategies include HPV vaccination, tailored cervical cancer screening, and antiviral suppression.
  • Open communication regarding gynecological health can enhance patient quality of life.

Related Concept Videos

Nursing Assessment of the Genitourinary System I: Health History01:21

Nursing Assessment of the Genitourinary System I: Health History

The genitourinary system is critical to maintaining fluid balance, waste elimination, and reproductive function. Nurses play a vital role in assessing this system, beginning with a thorough health history. This process involves gathering patient information, identifying risk factors, and recognizing symptoms of genitourinary disorders. Early detection is vital for timely interventions and management.1. Gathering Patient InformationA complete health history includes the patient’s personal,...
83
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
322
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
49
Assessment of the Gastrointestinal System I: Subjective Data01:17

Assessment of the Gastrointestinal System I: Subjective Data

Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
296
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.0K
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
432